Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
The Practitioner|November 9, 2017
Set individualized targets for patients with type 2 diabetesSurya Panicker Rajeev, John WildingCurrent Opinion in Pharmacology|September 5, 2016
GLP-1 as a target for therapeutic interventionSurya Panicker Rajeev, John WildingBMJ Case Reports|September 21, 2019
Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosisRoss Leader, Jake Cowen, Surya Panicker RajeevDiabetes Care|July 22, 2016
Positioning SGLT2 Inhibitors/Incretin-Based Therapies in the Treatment AlgorithmJohn P H Wilding, Surya Panicker Rajeev, Ralph A DeFronzoBMC Endocrine Disorders|August 25, 2014
Evolution in functionality of a metastatic pancreatic neuroendocrine tumour (pNET) causing Cushing's syndrome: treatment response with chemotherapySurya Panicker Rajeev, Steffan McDougall, Monica Terlizzo, et al.Current Opinion in Investigational Drugs (London, England : 2000)|May 12, 2004
AOD-9604 MetabolicJohn WildingThe British Journal of Developmental Psychology|January 11, 2011
Is attention impaired in ADHD?John WildingQuarterly Journal of Experimental Psychology (2006)|August 4, 2010
Development of a vocabulary of object shapes in a child with a very-early-acquired visual agnosia: a unique caseElaine Funnell, John WildingPageof 7